Can decisional algorithms replace global introspection in the individual causality assessment of spontaneously reported ADRs?

Drug Safety

Volumn 29, Issue 8, 2006, Pages 697-702

  Macedo, Ana F ^a,b   Marques, Francisco B ^a   Ribeiro, Carlos F ^a  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF BEIRA INTERIOR   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; ARTICLE; MEDICAL DECISION MAKING; MEDICAL EXPERT; MEDICAL RESEARCH; PRIORITY JOURNAL; PUBLICATION; SENSITIVITY AND SPECIFICITY; VALIDATION STUDY; WORLD HEALTH ORGANIZATION;

ADVERSE DRUG REACTION REPORTING SYSTEMS; ALGORITHMS; DECISION SUPPORT TECHNIQUES; EVALUATION STUDIES; EVALUATION STUDIES AS TOPIC; GASTROINTESTINAL DISEASES; HUMANS; PHARMACEUTICAL PREPARATIONS; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SKIN DISEASES; WORLD HEALTH ORGANIZATION;

EID: 33746785922     PISSN: 01145916     EISSN: 01145916     Source Type: Journal    
DOI: 10.2165/00002018-200629080-00006     Document Type: Article

References (48)

1. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998; 279 (15): 1200-5
2. Einarson TR. Drug related hospital admissions. Ann Pharmacother 1993; 27: 832-40
3. Muehlberger N, Schneeweiss S, Hasford J. Adverse drug reaction monitoring - cost and benefit considerations. Part I: frequency of adverse drug reactions causing hospital admissions. Pharmacoepidemiol Drug Saf 1997; 6 Suppl. 3: S71-7
4. Classen DC, Pestotnik SL, Evans RS, et al. Adverse drug events in hospitalized patients: excess length of stay, extra costs and attributable mortality. JAMA 1997; 277 (4): 301-6
5. Moore N, Lecointre D, Noblet C, et al. Frequency and cost of serious adverse drug reactions in a department of general medicine. Br J Clin Pharmacol 1998; 45: 301-8
6. Brennan TA, Leape LL, Laird NM, et al. Incidence of adverse drug events and negligence in hospitalized patients: results of the Harvard medical practice study I. N Engl J Med 1991; 324 (6): 370-6
7. Dormann H, Muth-Selbach U, Krebs S, et al. Incidence and costs of adverse drug reactions during hospitalisation. Drug Saf 2000; 22 (2): 161-8
8. Vincent C, Neale G, Wolhynowych M. Adverse events in British hospitals: preliminary retrospective record review. BMJ 2001; 322: 517-9
9. Winterstein AG, Sauer BC, Hepler CD, et al. Preventable drug-related hospital admissions. Ann Pharmacother 2002; 36: 1238-48
10. Karch FE, Smith CL, Kerzner B, et al. Adverse drug reactions a matter of opinion. Clin Pharmacol Ther 1976; 19: 489-92
11. Blanc S, Levenberger P, Berger JP, et al. Judgements of trained observers on adverse drug reactions. Clin Pharmacol Ther 1979; 25: 493-8
12. Karch FE, Lasagna L. Toward the operational identification of adverse drug reactions. Clin Pharmacol Ther 1977; 21: 247-54
13. Venulet J. Aspects of standardization as applied to the assessment of drug-event associations. Drug Inf J 1984; 18 (3/4): 199-210
14. Hutchinson TA, Flegel KM, Herbert H, et al. Reasons for disagreement in the standardized assessment of suspected adverse drug reactions. Clin Pharmacol Ther 1983; 34: 421-6
15. Dangoumau J, Begaud B, Boisseau A, et al. Methods for identification and imputation of drug side effects. Side effects: a fleeing reality, an illusive reality? [in French]. Therapie 1980; 35: 287-92
16. Begaud B, Boisseau A, Albin H, et al. Comparaison de quatre méthodes d'imputabilité des effets indésirables des médicaments. Therapie 1981; 36: 65-70
17. Leroy O, Begaud B, Dangoumau J, et al. Etude comparative de quatre méthodes d'imputabilité. Therapie 1981; 36: 223-7
18. Pere JC, Begaud B, Haramburu F, et al. Computerized comparison of six adverse drug reactions assessment procedures. Clin Pharmacol Ther 1986; 40: 451-61
19. Girard M. L'imputation en pharmacovigilance est-elle fiable? Therapie 1984; 39: 291-6
20. Pere JC, Begaud B, Haramburu F, et al. Méthodes d'étude des effets indésirables des medicaments: II. Profil et comparaison de cinq méthodes d'imputabilité. Therapie 1984; 39: 369-78
21. Frick PA, Cohen LG, Rovers JP. Algorithms used in adverse drug event reposts: a comparative study. Ann Pharmacother 1997; 31: 164-7
22. Michel DJ, Knodel LC. Comparison of three algorithms used to evaluate adverse drug reactions. Am J Hosp Pharm 1986; 43: 1709-14
23. Bate A, Lindquist M, Edwards IR, et al. A Bayesian neural network method for adverse drug reaction signal generation. Eur J Clin Pharmacol 1998; 54: 315-21
24. Lindquist M, Edwards IR, Bate A, et al. From association to alert -a revised approach to international signal analysis. Pharmacoepidemiol Drug Saf 1999; 8: S15-25
25. van Puijenbroek E, Diemont W, van Grootheest K. Application of quantitative signal detection in the Dutch spontaneous reporting system for adverse drug reactions. Drug Saf 2003; 26 (5): 293-301
26. van Puijenbroek EP, Bate A, Leufkens HG, et al. A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions. Pharmacoepidemiol Drug Saf 2002; 11: 3-10
27. Macedo AF, Marques FB, Ribeiro CF, et al. Causality assessment of adverse drug reactions: comparison of the results obtained from published decisional algorithms and from the evaluations of an expert panel, according to different levels of imputability. J Clin Pharmacol Ther 2003; 28: 137-43
28. Macedo AF, Marques FB, Ribeiro CF, et al. Causality assessment of adverse drug reactions: comparison of the results obtained from published decisional algorithms and from the evaluations of an expert panel. Pharmacoepidemiol Drug Saf 2005; 14: 885-90
29. Mashford ML. The Australian method of drug-event assessment. Drug Inf J 1984; 18: 271-3
30. Stephens MD. The diagnosis of adverse medical events associated with drug treatment. Adverse Drug React Acute Poisoning Rev 1987; 1: 1-35
31. Dangoumau J, Evreux JC, Jouglard J. Méthode d'imputabilité des effets indésirables des médicaments. Therapie 1978; 33: 373-81
32. Begaud B, Evreux JLC, Jouglard JC, et al. Imputabilité des effets inattendus ou toxiques des médicaments: actualisation de la méthode utilisée en France. Therapie 1985; 40: 111-4
33. Emanueli A. A simple algorithm for assessing causality of adverse reactions. Special Workshop-Industrial. Drug Inf J 1984; 18: 303-6
34. Hsu P-H, Stoll RW. Causality assessment of adverse events in clinical trials: II. an algorithm for drug causality assessment. Drug Inf J 1993; 27: 387-94
35. Irey NS. Tissue reactions to drugs. Am J Pathol 1976; 82: 617-48
36. Jones JK. Adverse drug reactions in the community health setting: approaches to recognizing, counselling and reporting. Fam Community Health 1982; 5 (2): 58-67
37. Kitaguchi T, Nojiri T, Suzuki S, et al. Some assessment systems for industry post marketing adverse drug reaction (ADR) information. Iyakuhin Kenkyu 1983; 14: 980-93
38. Kramer MS, Leventhal JM, Hutchinson TA, et al. An algorithm for the operational assessment of adverse drug reactions: I. Background, description and instructions for use. JAMA 1979; 242: 623-32
39. Hutchinson TA, Leventhal JM, Kramer MS, et al. An algorithm for the operational assessment of adverse drug reactions: II. Demonstration of reproducibility and validity. JAMA 1979; 242: 633-8
40. Leventhal JM, Hutchinson TA, Kramer MS, et al. An algorithm for the operational assessment of adverse drug reactions: III. Results of tests among clinicians. JAMA 1979; 242: 1991-4
41. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30: 239-45
42. Stephens MD. Assessment of causality in industrial setting. Special Workshop-Industrial. Drug Inf J 1984; 18: 307-13
43. Venulet J, Ciucci A, Berneker GC. Updating of a method for causality assessment of adverse drug reactions. Int J Clin Pharmacol Ther Toxicol 1986; 24: 559-68
44. Weber JCP. Storage and retrieval of data on adverse reactions to drugs. Brighton: Interphex Symposium, 1980
45. Causality assessment of suspected adverse drug reaction. WHO-UMC [online]. Available from URL: http://www.who-umc.org/DynPage.aspx?.id=22682 [Accessed 2006 Jan31]
46. World Health Organization criteria for serious adverse event or reaction [online]. Available from URL: http://www.who-umc.org/DynPage.aspx?.id=22680 [Accessed 2006 Jan 31]
47. Parfitt K. Martindale: the complete drug reference. 32nd ed. Grayslake (IL): Pharmaceutical Press. 1999
48. Stahl M, Lindquist M, Edwards IR, et al. Introducing triage logic as a new strategy for the detection of signals in the WHO Drug Monitoring Database. Pharmacoepidemiol Drug Saf 2004; 13: 355-63